Hosted on MSN

Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug

Gilead stock toppled Thursday after CVS HealthCVS said it won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now. The decision is based on clinical, financial and ...
Yahoo

FDA approves powerful HIV drug that nearly eliminated spread in clinical trials

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

Gilead posts higher profit on demand for HIV drugs, but overall sales dip

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

GSK boss Emma Walmsley bows out as HIV and cancer drugs supercharge sales

GSK lifted profit expectations for the year after the pharma group's sales were boosted by bumper demand for HIV and cancer ...
Yahoo

CVS Health denies coverage for breakthrough HIV drug, committing 'clear violation' of ACA

CVS Health has denied coverage for a new HIV prevention drug despite it being nearly 100 percent effective, citing in part the medication's high cost. The nation's largest pharmacy benefit manager ...
Brown University

Brown team to co-lead $12M study to improve well-being of people who use drugs in New England

With a focus on Massachusetts, Rhode Island and Vermont, a project funded by the National Institute on Drug Abuse will analyze trends in drug use and barriers to care with the goal of strengthening ...